Fennec Pharmaceuticals
FENC
#7984
Rank
A$0.57 B
Marketcap
A$16.36
Share price
-4.98%
Change (1 day)
N/A
Change (1 year)

Earnings for Fennec Pharmaceuticals (FENC)

Earnings in 2026 (TTM): -A$4.75 Million

According to Fennec Pharmaceuticals's latest financial reports the company's current earnings are A$59.22 Million. In 2025 the company made an earning of -A$13.33 Million a decrease over its 2024 earnings that were of -A$0.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fennec Pharmaceuticals from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.75 Million-64.37%
2025 -A$13.33 Million13471.83%
2024 -A$0.1 Million-99.56%
2023 -A$22.19 Million-32.34%
2022 -A$32.8 Million36.71%
2021 -A$23.99 Million-4.21%
2020 -A$25.05 Million41.75%
2019 -A$17.67 Million29.2%
2018 -A$13.68 Million40.33%
2017 -A$9.75 Million152.64%
2016 -A$3.86 Million323.22%
2015 -A$0.92 Million-69.72%
2014 -A$3.01 Million-218%
2013 A$2.55 M-240.02%
2012 -A$1.83 Million-128.1%
2011 A$6.48 M-327.81%
2010 -A$2.85 Million-19.77%
2009 -A$3.55 Million-81.44%
2008 -A$19.11 Million-0.81%
2007 -A$19.27 Million-30.68%
2006 -A$27.79 Million-6.69%
2005 -A$29.79 Million
2003 -A$11.85 Million82.16%
2002 -A$6.51 Million9.38%
2001 -A$5.95 Million